| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/21/2014 | CA2546083C Novel brevibacillus choshinensis and method for producing protein using the microorganism as host |
| 01/21/2014 | CA2495177C Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 01/21/2014 | CA2478047C Rs7 antibodies |
| 01/21/2014 | CA2465202C Phytase-containing animal food and method |
| 01/21/2014 | CA2459893C Methods and apparatus for conducting multiple measurements on a sample |
| 01/21/2014 | CA2441688C Compositions and methods useful for hcv infection |
| 01/21/2014 | CA2427257C Expression vectors able to elicit improved immune response and methods of using same |
| 01/21/2014 | CA2414374C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/21/2014 | CA2413175C Sequence specific dna recombination in eukaryotic cells |
| 01/21/2014 | CA2394367C Method to enhance agrobacterium-mediated transformation of plants |
| 01/21/2014 | CA2388477C Recombinant gelatins with uniform molecular weight |
| 01/21/2014 | CA2378437C Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 01/21/2014 | CA2371995C Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 01/21/2014 | CA2359317C Method of treating restenosis by antisense targeting of c-myc |
| 01/21/2014 | CA2354185C Transgenic plants and methods for production thereof |
| 01/21/2014 | CA2341763C Antigenic peptides of aglyco 10b and antibodies thereto |
| 01/21/2014 | CA2236868C Conditionally replicating viral vectors and their use |
| 01/16/2014 | WO2014012115A2 Method for inducing cells to less mature state |
| 01/16/2014 | WO2014012108A1 Cellular and animal models for screening therapeutic agents for the treatment of alzheimer's disease |
| 01/16/2014 | WO2014012090A1 Molecular sleds comprising a positively-charged amino acid sequence and a molecular cargo and uses thereof |
| 01/16/2014 | WO2014012055A1 Biorefinery system, methods and compositions thereof |
| 01/16/2014 | WO2014012047A1 Systems and methods for diagnosis, prognosis, and treatment of cancer |
| 01/16/2014 | WO2014011829A1 Protein complex system for increased immunogenicity and functionality, and methods making and use |
| 01/16/2014 | WO2014011817A2 Genome surgery with paired, permeant endonuclease excision |
| 01/16/2014 | WO2014011800A1 Methods for multipart, modular and scarless assembly of dna molecules |
| 01/16/2014 | WO2014011660A1 Methods and compositions for influencing the transport of molecular species through biological barriers |
| 01/16/2014 | WO2014011512A1 Compositions and methods for "resistance-proof" sirna therapeutics for influenza |
| 01/16/2014 | WO2014011407A2 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof |
| 01/16/2014 | WO2014011237A1 Methods and compositions for the treatment of lysosomal storage diseases |
| 01/16/2014 | WO2014011053A1 Oligonucleotides for making a change in the sequence of a target rna molecule present in a living cell |
| 01/16/2014 | WO2014011050A1 Exon replacement with stabilized artificial rnas |
| 01/16/2014 | WO2014011024A1 A codon-optimized gene for producing fish growth hormone |
| 01/16/2014 | WO2014011003A1 Crystallization method for trx-txnip complex denatured protein, and three-dimensional structure thereof |
| 01/16/2014 | WO2014010806A1 Information providing method for diagnosing tuberculosis using ip-10 mrna targeted real-time reverse transcriptase-polymer chain reaction |
| 01/16/2014 | WO2014010782A1 Antibody specific to human blood coagulation factor viii domain and method for producing same |
| 01/16/2014 | WO2014010758A1 Anti-tumour agent, marker for tumour detection, and oral vaccine agent |
| 01/16/2014 | WO2014010746A1 Brown fat cells and method for preparing same |
| 01/16/2014 | WO2014010718A1 Chiral nucleic acid adjuvant |
| 01/16/2014 | WO2014010640A1 Method for producing aptamer |
| 01/16/2014 | WO2014010603A1 Pharmaceutical composition for treating or preventing stress urinary incontinence or mixed incontinence, and method for screening compounds to be included in said pharmaceutical composition |
| 01/16/2014 | WO2014010232A1 Ly6k epitope peptides for th1 cells and vaccines containing the same |
| 01/16/2014 | WO2014010231A1 Kif20a epitope peptides for th1 cells and vaccines containing the same |
| 01/16/2014 | WO2014010229A1 Cdca1 epitope peptides for th1 cells and vaccines containing the same |
| 01/16/2014 | WO2014009908A2 Transgenic camelina sativa plant having modified fatty acid contents of seed oil |
| 01/16/2014 | WO2014009609A1 Combination therapy iii |
| 01/16/2014 | WO2014009586A2 Mutant strains of mycoplasma hyopneumoniae |
| 01/16/2014 | WO2014009567A1 Compositions and methods for duchenne muscular dystrophy gene therapy |
| 01/16/2014 | WO2014009515A1 Method for producing a recombinant protein of interest |
| 01/16/2014 | WO2014008729A1 Method of eliminating dependence of methanol induced promoter on single methanol carbon source |
| 01/16/2014 | WO2013177265A8 A QUANTITATIVE MULTIPLEX METHYLATION SPECIFIC PCR METHOD- cMethDNA, REAGENTS, AND ITS USE |
| 01/16/2014 | WO2013177231A8 Translocation of non-natural chemical entities through anthrax protective antigen pore |
| 01/16/2014 | WO2013166264A3 Methods for altering virus replication |
| 01/16/2014 | WO2013164793A3 Viral vectors for the treatment of retinal dystrophy |
| 01/16/2014 | WO2013163292A3 Methods and microorganisms for increasing the biological synthesis of difunctional alkanes |
| 01/16/2014 | WO2013128409A3 De novo integron recombination sites and uses thereof |
| 01/16/2014 | WO2013052814A8 E1 enzyme mutants and uses thereof |
| 01/16/2014 | WO2009046535A8 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 01/16/2014 | US20140020138 Transgenic plants expressing dispersinb |
| 01/16/2014 | US20140020135 Novel Use of a Dense and Erect Panicle 1 Gene in Improving Nitrogen Utilization Efficiency |
| 01/16/2014 | US20140020134 Fruit-specific promoter |
| 01/16/2014 | US20140020133 Genetically Engineered Plants with Increased Vegetative Oil Content |
| 01/16/2014 | US20140020132 Plants having increased desiccation tolerance, increased drought tolerance or increased water use efficiency |
| 01/16/2014 | US20140020131 Methods and compositions for producing male sterile plants |
| 01/16/2014 | US20140020130 csRRM2 GENE AND ITS USE FOR IMPROVING TRAITS IN INDUSTRIAL CROPS |
| 01/16/2014 | US20140020129 Lettuce variety 41-137 rz, "delibes rz" |
| 01/16/2014 | US20140020126 Mirna expression vector |
| 01/16/2014 | US20140020125 Methods of Modifying Eukaryotic Cells |
| 01/16/2014 | US20140020124 Methods of Modifying Eukaryotic Cells |
| 01/16/2014 | US20140018527 Methods and compositions for the treatment of eye disorders with increased intraocular pressure |
| 01/16/2014 | US20140018522 Methods of Modifying Eukaryotic Cells |
| 01/16/2014 | US20140018445 Method for detection of pathogenic organisms |
| 01/16/2014 | US20140018413 Mirna lentivirus vector |
| 01/16/2014 | US20140018412 Methods for Diagnosing Lung Cancer using MicroRNAs |
| 01/16/2014 | US20140018411 Methods for Diagnosing Prostate Cancer using MicroRNAs |
| 01/16/2014 | US20140018410 Compositions and methods for inhibiting expression of klf-1 and bcl11a genes |
| 01/16/2014 | US20140018408 Oligonucleotides for treating inflammation and neoplastic cell proliferation |
| 01/16/2014 | US20140018306 Methods and compositions for treating ocular disorders |
| 01/16/2014 | US20140018296 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY |
| 01/16/2014 | US20140018283 Subtilase Variants |
| 01/16/2014 | US20140018264 Reducing adapter dimer formation |
| 01/16/2014 | US20140018261 Focused libraries of genetic packages |
| 01/16/2014 | US20140018245 Marker sequences for multiple sclerosis and use thereof |
| 01/16/2014 | US20140017792 Vector particles for targeting cd34+ cells |
| 01/16/2014 | US20140017782 Methods for Modifying Eukaryotic Cells |
| 01/16/2014 | US20140017781 Methods of Modifying Eukaryotic Cells |
| 01/16/2014 | US20140017780 MicroRNAs and uses thereof |
| 01/16/2014 | US20140017774 Pca3, pca3 genes, and methods of use |
| 01/16/2014 | US20140017768 XYLOSE ISOMERASE AND XYLITOL DEHYDROGENASE COMBINATION FOR XYLOSE FERMENTATION TO ETHANOL AND B. fragilis XYLOSE ISOMERASE |
| 01/16/2014 | US20140017766 Targeting pseudotyped retroviral vectors |
| 01/16/2014 | US20140017765 Pentose fermentation by a recombinant microorganism |
| 01/16/2014 | US20140017726 Modified human cmv promoters that are resistant to gene silencing |
| 01/16/2014 | US20140017725 Methods of Making Nanotechnological and Macromolecular Biomimetic Structures |
| 01/16/2014 | US20140017695 Isolating cells expressing secreted proteins |
| 01/16/2014 | US20140017672 Method and kit for purifying nucleic acids |
| 01/16/2014 | US20140017668 COMPOSITIONS AND METHODS FOR DETECTING AND QUANTIFYING CIRCULATING TUMOR CELLS (CTCs) |
| 01/16/2014 | US20140017300 Delivery of nucleic acid-like compounds |
| 01/16/2014 | US20140017273 Albumin-Fused Anti-Angiogenesis Peptides |
| 01/16/2014 | US20140017272 Transgenic algae for delivering antigens to an animal |
| 01/16/2014 | US20140017260 Methods and materials for reducing bone loss |
| 01/16/2014 | US20140017238 Methods of Modifying Eukaryotic Cells |